A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

19 hours ago

AstraZeneca's trial flop raises a bigger question: Is its pipeline premium too vulnerable?

19 hours ago

Abivax $920 million cash haul lets it prepare for solo U.S. launch instead of relying on a buyer

1 day ago

AstraZeneca stock drops after clinical trial miss deals rare blow to pharma powerhouse

1 day ago

Employers aren't expanding coverage of GLP-1 obesity drugs, survey says

2 days ago

Jim Cramer says these are the 5 stocks to buy during this market rotation

5 days ago

Ebola outbreak harder to contain after USAID, Western aid cuts, experts say

5 days ago

Jim Cramer says this former Covid market darling is finally investable again

10 days ago

Walmart, CVS step in to help seniors with Medicare coverage of obesity drugs

10 days ago

FDA lets Philip Morris market Zyn nicotine pouches as less harmful than cigarettes

11 days ago

Cramer says this aerospace stock is significantly undervalued, sees 35% upside

11 days ago

Medicare will start covering obesity drugs. Here's what patients should know

11 days ago

French biotech stock soars 40% after new data on experimental medicine

11 days ago

FDA names first companies chosen for faster review of new manufacturing plants

12 days ago

Medicare is about to cover obesity drugs — but many seniors may not know it yet

13 days ago

Estrogen patches are hard to find, and it may not be resolved any time soon

15 days ago

Chan Zuckerberg Initiative's Biohub to open new rare disease funding round

16 days ago

This life sciences stock has a secret weapon, and AI will only make it more valuable

17 days ago

Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy

17 days ago

UPS to invest $48 million in cold facilities amid GLP-1 boom

18 days ago

SNAP restrictions could change what shoppers buy — and food giants are watching

21 days ago

U.S. opens tariff probe targeting Germany's drug pricing policies

22 days ago

What this biotech's volatile stock price tells you about the weight loss market right now

23 days ago

UniQure to seek FDA approval for Huntington's disease gene therapy in reversal

23 days ago

Biotech IPO revival faces competition from cash-rich big pharma buyers

25 days ago

Centene to offer buyouts to some employees as health insurer cuts costs

26 days ago

Drugmakers race to find a place in the next wave of obesity drugs

28 days ago

CVS Health executives on reducing healthcare's biggest pain points

28 days ago

Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'

1 month ago

How screwworm in U.S. cattle herds could re-inflate record beef prices

1 month ago

The space race is coming for pharma: Why drug development is heading to orbit

1 month ago

Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion

1 month ago